MY KOLKATA EDUGRAPH
ADVERTISEMENT
regular-article-logo Monday, 23 June 2025

Novo Nordisk ends collaboration with Hims & Hers over weight loss drug

Novo Nordisk said in a statement on Monday that direct access to Wegovy would no longer be available to Hims & Hers Health via the NovoCare Pharmacy

Reuters Published 23.06.25, 06:27 PM
File photo: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024.

File photo: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Reuters

Novo Nordisk said on Monday it would halt its collaboration with Hims & Hers Health over the sale of weight loss drugs.

The two companies had announced a collaboration in April for Hims & Hers to sell Novo's blockbuster Wegovy weight loss drug through a bundled offering on the telehealth company's platform.

Novo Nordisk said in a statement on Monday that direct access to Wegovy would no longer be available to Hims & Hers Health via the NovoCare Pharmacy.

RELATED TOPICS

Follow us on:
ADVERTISEMENT
ADVERTISEMENT